TSX · BLCO.TO
Bausch + Lomb Corporation
CA$28.25-CA$0.50 (-1.74%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.98% below the high.
Loading market information…
TSX · WLLW.TO · CAD
Stock price, earnings
Quote as of Jun 20, 2025, 07:58 PM UTC. Cached market data; not a live quote.
One-year closing-price history · CAD. Historical prices are not a forecast.
Willow Biosciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.17% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Willow Biosciences Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Founded in 1981 and headquartered in Calgary, Canada, Willow Biosciences Inc. operates as a biotechnology enterprise. The company is dedicated to the creation, manufacturing, and distribution of plant-derived compounds, primarily serving the consumer care, food and beverage, and pharmaceutical industries across Canada. A core part of its product portfolio includes cannabidiol (CBD), cannabigerol (CBG), and various varin cannabinoids, such as cannabigerovarin (CBGV), cannabidivarin (CBDV), and tetrahydrocannabivarin (THCV).
Latest available per-share figures in CAD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 04:21 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
CA$28.25-CA$0.50 (-1.74%)
Bausch + Lomb Corporation’s quoted price sits in the upper half of its reported 52-week range, 4.98% below the high.
CA$33.40-CA$0.27 (-0.8%)
Apotex Health Corp.’s quoted price sits in the upper half of its reported 52-week range, 16.87% below the high.
CA$0.04+CA$0.01 (+33.33%)
The BC Bud Corporation’s quoted price sits in the lower half of its reported 52-week range, 74.19% below the high.
CA$0.01CA$0.00 (0.0%)
Heritage Cannabis Holdings Corp.’s quoted price sits in the lower half of its reported 52-week range, 75.0% below the high.
$5.93+$0.08 (+1.37%)
Clearmind Medicine Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.78% below the high.
CA$0.01+CA$0.01 (+100.0%)
Luff Enterprises Ltd.: Healthcare · Drug Manufacturers - Specialty & Generic.
CA$0.01-CA$0.01 (-33.33%)
Filament Health Corp.’s quoted price sits in the lower half of its reported 52-week range, 85.71% below the high.
$0.00$0.00 (0.0%)
StageZero Life Sciences Ltd.’s quoted price sits in the lower half of its reported 52-week range, 91.45% below the high.
